CARDIAC SURGERY

Evaluation of solitary pulmonary nodule

Feb 24, 2017 by in CARDIAC SURGERY Comments Off on Evaluation of solitary pulmonary nodule

>20–40 mm>40 mm0–30 mm>30 mm31185431174.1%66.6%100%72.1%81.8%0.4220.378Makris D et al., 2007 [31]ENB0–10 mm>10–20 mm>20–30 mm>30 mm41671375%43.7%71.4%76.9%Not reportedLamprecht B et al., 2012 [32]Combined FDG-PET, ENB, and ROSE0–20 mm>20 mm456775.6%89.6%0.066Pearlstein DP et al., 2012[33]ENB…

read more

Benign esophageal disease

Feb 24, 2017 by in CARDIAC SURGERY Comments Off on Benign esophageal disease

Abnormal (>45 mmHg)>8 mmHg0010 contractionsDistal esophageal spasmNormal (≤45 mmHg)Abnormal (>45 mmHg)Normal(≤8 mmHg)Abnormal(>8 mmHg)1–8≤2 waves≥2 contractions≤9 contractionsHypercontractile motilityHypertensive LESNutcracker esophagus>45 mmHg≤8 mmHg7–10 wavesb≤2 waves≤1 contractionHypocontractile motilityHypotensive LESIneffective esophageal motility<10 mmHg≤8 mmHg0–7…

read more

Primary spontaneous pneumothorax

Feb 24, 2017 by in CARDIAC SURGERY Comments Off on Primary spontaneous pneumothorax

Metastases to lung Epidemiology PSP has an incidence of 7.4 to 18 cases (age-adjusted incidence) per 100,000 population each year in males and 1.2 to 6 cases per 100,000 population…

read more

Pulmonary metastasectomy

Feb 24, 2017 by in CARDIAC SURGERY Comments Off on Pulmonary metastasectomy

Figure 17.1 Chest CT scan showing single pulmonary metastasis located in the left superior lobe originating from colorectal carcinoma excised by thoracoscopic wedge. Pulmonary reserve Complete pulmonary function and a…

read more

Medical treatment of lung cancer (neo and adjuvant chemoradiotherapy)

Feb 24, 2017 by in CARDIAC SURGERY Comments Off on Medical treatment of lung cancer (neo and adjuvant chemoradiotherapy)

61 (at 24 mo)723—0.047UFT meta-analysis[14]2003I-IIIUFT/observation806.44 (years)4.60.770.011NCIC-JBR10 Trial[6,7]482IB-IICis-VNB/observation6560150.690.011CALGB 9633 Trial[12]344IBPCL-carboplatin/observation854830.800.32ANITA Trial[9]840IB-IIIACis-VNB/observation56 ##>708.60.790.013 * Estimated 5-year survival rates were 39% for the RT only group and 33% for the CT-RT group. **…

read more

Pathological considerations in lung malignancy

Feb 24, 2017 by in CARDIAC SURGERY Comments Off on Pathological considerations in lung malignancy

TTF-1, CD56 -ve, CK7+/-Adenocarcinoma & large cell carcinomaTTF-1 (~70%), CK7+CK5/6, p40, CD56 -veSmall cell carcinoma & large cell neuroendocrine carcinomaCD56, synaptophysin, CK7 +veTTF-1 + (70-80%) (CK = cytokeratin, TTF-1 =…

read more

Lung cancer staging

Feb 24, 2017 by in CARDIAC SURGERY Comments Off on Lung cancer staging

Figure 12.1 Mountain and Dresler lymph node map[4] (used with permission). References 1Rostad H, Vale JR, Nesthus I. Lung cancer: symptoms, signs and diagnostic criteria. Scand J Respir Dis 1979;…

read more

Therapeutic bronchoscopy

Feb 24, 2017 by in CARDIAC SURGERY Comments Off on Therapeutic bronchoscopy

html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 5 Therapeutic bronchoscopy Keyvan Moghissi Core Topics in Thoracic Surgery, ed. Marco Scarci, Aman Coonar, Tom Routledge and Francis Wells. Published by Cambridge University Press….

read more

Maximizing Vein Conduit for Autogenous Bypass

Aug 7, 2016 by in CARDIAC SURGERY Comments Off on Maximizing Vein Conduit for Autogenous Bypass

■  Ideal conduit diameter is 3.5 mm or greater. ■  Vein should be easily compressible. Thick-walled or noncompressible vein indicates prior superficial venous thrombosis and vein is likely not suitable for bypass….

read more
Get Clinical Tree app for offline access